Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Breast Cancer Res Treat. 2012 Sep 27;136(1):253–265. doi: 10.1007/s10549-012-2262-7

Table 4.

Multivariate analysis of time to recurrence for tamoxifen-untreated, ER+ patients (n = 435)

Variable HR 95 % CI P
Nuclear 0.004
 1st quartile (≤4) 1.00
 Others (5–8) 1.94 1.24–3.04
Cytoplasm 0.259
 Negative (= 0) 1.25 0.85–1.83
 Positive ( >0) 1.00
Node <0.0001
 Node negative 1.00
 1–3 1.53 0.93–2.51
 >3 3.42 1.94–6.06